<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37175422</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>23</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Role of Coxsackievirus B3-Induced Immune Responses in the Transition from Myocarditis to Dilated Cardiomyopathy and Heart Failure.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7717</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24097717</ELocationID><Abstract><AbstractText>Dilated cardiomyopathy (DCM) is a cardiac disease marked by the stretching and thinning of the heart muscle and impaired left ventricular contractile function. While most patients do not develop significant cardiac diseases from myocarditis, disparate immune responses can affect pathological outcomes, including DCM progression. These altered immune responses, which may be caused by genetic variance, can prolong cytotoxicity, induce direct cleavage of host protein, or encourage atypical wound healing responses that result in tissue scarring and impaired mechanical and electrical heart function. However, it is unclear which alterations within host immune profiles are crucial to dictating the outcomes of myocarditis. Coxsackievirus B3 (CVB3) is a well-studied virus that has been identified as a causal agent of myocarditis in various models, along with other viruses such as adenovirus, parvovirus B19, and SARS-CoV-2. This paper takes CVB3 as a pathogenic example to review the recent advances in understanding virus-induced immune responses and differential gene expression that regulates iron, lipid, and glucose metabolic remodeling, the severity of cardiac tissue damage, and the development of DCM and heart failure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yip</LastName><ForeName>Fione</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Brian</ForeName><Initials>B</Initials><Identifier Source="ORCID">0009-0003-6197-0334</Identifier><AffiliationInfo><Affiliation>The Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Decheng</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3177-0070</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RGPIN-2017-05612</GrantID><Agency>Natural Sciences and Engineering Research Council</Agency><Country /></Grant><Grant><GrantID>PJT169202</GrantID><Agency>Canada Institute of Public Health Research</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002311" MajorTopicYN="Y">Cardiomyopathy, Dilated</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coxsackievirus B3 (CVB3)</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">differentially expressed genes</Keyword><Keyword MajorTopicYN="N">dilated cardiomyopathy (DCM)</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">metabolic remodeling</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>15</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37175422</ArticleId><ArticleId IdType="pmc">PMC10178405</ArticleId><ArticleId IdType="doi">10.3390/ijms24097717</ArticleId><ArticleId IdType="pii">ijms24097717</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rezkalla S.H., Kloner R.A. Viral myocarditis: 1917–2020: From the Influenza A to the COVID-19 pandemics. Trends Cardiovasc. Med. 2021;31:163–169. doi: 10.1016/j.tcm.2020.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7965406</ArticleId><ArticleId IdType="pubmed">33383171</ArticleId></ArticleIdList></Reference><Reference><Citation>Mele D., Flamigni F., Rapezzi C., Ferrari R. Myocarditis in COVID-19 patients: Current problems. Intern. Emerg. Med. 2021;16:1123–1129. doi: 10.1007/s11739-021-02635-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02635-w</ArticleId><ArticleId IdType="pmc">PMC7823176</ArticleId><ArticleId IdType="pubmed">33484452</ArticleId></ArticleIdList></Reference><Reference><Citation>Bock C.-T., Klingel K., Kandolf R. Human Parvovirus B19–Associated Myocarditis. N. Engl. J. Med. 2010;362:1248–1249. doi: 10.1056/NEJMc0911362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc0911362</ArticleId><ArticleId IdType="pubmed">20357294</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles N.E., Ni J., Kearney D.L., Pauschinger M., Schultheiss H.P., McCarthy R., Hare J., Bricker J.T., Bowles K.R., Towbin J.A. Detection of viruses in myocardial tissues by polymerase chain reaction: Evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol. 2003;42:466–472. doi: 10.1016/S0735-1097(03)00648-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(03)00648-X</ArticleId><ArticleId IdType="pubmed">12906974</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasrado N., Reddy J. An overview of the immune mechanisms of viral myocarditis. Rev. Med. Virol. 2020;30:e2131. doi: 10.1002/rmv.2131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2131</ArticleId><ArticleId IdType="pubmed">32720461</ArticleId></ArticleIdList></Reference><Reference><Citation>Kühl U., Pauschinger M., Seeberg B., Lassner D., Noutsias M., Poller W., Schultheiss H.-P. Viral Persistence in the Myocardium Is Associated with Progressive Cardiac Dysfunction. Circulation. 2005;112:1965–1970. doi: 10.1161/CIRCULATIONAHA.105.548156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.548156</ArticleId><ArticleId IdType="pubmed">16172268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearney M., Cotton J., Richardson P., Shah A. Viral myocarditis and dilated cardiomyopathy: Mechanisms, manifestations, and management. Postgrad. Med. J. 2001;77:4–10. doi: 10.1136/pmj.77.903.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pmj.77.903.4</ArticleId><ArticleId IdType="pmc">PMC1741887</ArticleId><ArticleId IdType="pubmed">11123385</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichart D., Magnussen C., Zeller T., Blankenberg S. Dilated cardiomyopathy: From epidemiologic to genetic phenotypes. J. Intern. Med. 2019;286:362–372. doi: 10.1111/joim.12944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12944</ArticleId><ArticleId IdType="pubmed">31132311</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub R.G., Semsarian C., Macdonald P. Dilated cardiomyopathy. Lancet. 2017;390:400–414. doi: 10.1016/S0140-6736(16)31713-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31713-5</ArticleId><ArticleId IdType="pubmed">28190577</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard E.G. Viral Myocarditis, Pediatr. Infect. Dis. J. 2004;23:665–666. doi: 10.1097/01.inf.0000132280.36984.a9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000132280.36984.a9</ArticleId><ArticleId IdType="pubmed">15247607</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowlton K.U. Dilated Cardiomyopathy. Circulation. 2019;139:2339–2341. doi: 10.1161/CIRCULATIONAHA.119.040037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.040037</ArticleId><ArticleId IdType="pubmed">31082299</ArticleId></ArticleIdList></Reference><Reference><Citation>Chau D.H.W., Yuan J., Zhang H., Cheung P., Lim T., Liu Z., Sall A., Yang D. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis. 2007;12:513–524. doi: 10.1007/s10495-006-0013-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-006-0013-0</ArticleId><ArticleId IdType="pubmed">17195095</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Y., Ye X., Zhang H.M., Hanson P., Zhao G., Tong L., Xie R., Yang D. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication. PLoS Pathog. 2017;13:e1006744. doi: 10.1371/journal.ppat.1006744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006744</ArticleId><ArticleId IdType="pmc">PMC5738146</ArticleId><ArticleId IdType="pubmed">29220410</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao G., Zhang H.M., Qiu Y., Ye X., Yang D. Cleavage of Desmosomal Cadherins Promotes γ-Catenin Degradation and Benefits Wnt Signaling in Coxsackievirus B3-Induced Destruction of Cardiomyocytes. Front. Microbiol. 2020;11:767. doi: 10.3389/fmicb.2020.00767.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00767</ArticleId><ArticleId IdType="pmc">PMC7225294</ArticleId><ArticleId IdType="pubmed">32457708</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamud Y., Xue Y.C., Liu H., Ng C.S., Bahreyni A., Luo H. Autophagy Receptor Protein Tax1-Binding Protein 1/TRAF6-Binding Protein Is a Cellular Substrate of Enteroviral Proteinase. Front. Microbiol. 2021;12:647410. doi: 10.3389/fmicb.2021.647410.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.647410</ArticleId><ArticleId IdType="pmc">PMC8213198</ArticleId><ArticleId IdType="pubmed">34149637</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson P.J., Ye X., Qiu Y., Zhang H.M., Hemida M.G., Wang F., Lim T., Gu A., Cho B., Kim H., et al. Cleavage of DAP5 by coxsackievirus B3 2A protease facilitates viral replication and enhances apoptosis by altering translation of IRES-containing genes. Cell Death Differ. 2016;23:828–840. doi: 10.1038/cdd.2015.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.145</ArticleId><ArticleId IdType="pmc">PMC4832101</ArticleId><ArticleId IdType="pubmed">26586572</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A., Morosky S.A., Delorme-Axford E., Dybdahl-Sissoko N., Oberste M.S., Wang T., Coyne C.B. The Coxsackievirus B 3Cpro Protease Cleaves MAVS and TRIF to Attenuate Host Type I Interferon and Apoptotic Signaling. PLoS Pathog. 2011;7:e1001311. doi: 10.1371/journal.ppat.1001311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001311</ArticleId><ArticleId IdType="pmc">PMC3059221</ArticleId><ArticleId IdType="pubmed">21436888</ArticleId></ArticleIdList></Reference><Reference><Citation>Deonarain R., Cerullo D., Fuse K., Liu P.P., Fish E.N. Protective Role for Interferon-β in Coxsackievirus B3 Infection. Circulation. 2004;110:3540–3543. doi: 10.1161/01.CIR.0000136824.73458.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000136824.73458.20</ArticleId><ArticleId IdType="pubmed">15249500</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay S., Marques J.T., Yamashita M., Peters K.L., Smith K., Desai A., Williams B.R., Sen G.C. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J. 2010;29:1762–1773. doi: 10.1038/emboj.2010.50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.50</ArticleId><ArticleId IdType="pmc">PMC2876960</ArticleId><ArticleId IdType="pubmed">20360684</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y., Moore C.B., Liesman R.M., O’Connor B.P., Bergstralh D.T., Chen Z.J., Pickles R.J., Ting J.P.-Y. MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins. PLoS ONE. 2009;4:e5466. doi: 10.1371/journal.pone.0005466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005466</ArticleId><ArticleId IdType="pmc">PMC2674933</ArticleId><ArticleId IdType="pubmed">19404494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser W.J., Offermann M.K. Apoptosis Induced by the Toll-Like Receptor Adaptor TRIF Is Dependent on Its Receptor Interacting Protein Homotypic Interaction Motif. J. Immunol. 2005;174:4942–4952. doi: 10.4049/jimmunol.174.8.4942.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.8.4942</ArticleId><ArticleId IdType="pubmed">15814722</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson Z.I., Doolittle A.C., Snuggs J.W., Shapiro I.M., Le Maitre C.L., Risbud M.V. TNF-α promotes nuclear enrichment of the transcription factor TonEBP/NFAT5 to selectively control inflammatory but not osmoregulatory responses in nucleus pulposus cells. J. Biol. Chem. 2017;292:17561–17575. doi: 10.1074/jbc.M117.790378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.790378</ArticleId><ArticleId IdType="pmc">PMC5655530</ArticleId><ArticleId IdType="pubmed">28842479</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Wong J., Piesik P., Fung G., Zhang J., Jagdeo J., Li X., Jan E., Luo H. Cleavage of sequestosome 1/p62 by an enteroviral protease results in disrupted selective autophagy and impaired NFKB signaling. Autophagy. 2013;9:1591–1603. doi: 10.4161/auto.26059.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.26059</ArticleId><ArticleId IdType="pubmed">23989536</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahnefeld A., Klingel K., Schuermann A., Diny N.L., Althof N., Lindner A., Bleienheuft P., Savvatis K., Respondek D., Opitz E., et al. Ubiquitin-Like Protein ISG15 (Interferon-Stimulated Gene of 15 kDa) in Host Defense Against Heart Failure in a Mouse Model of Virus-Induced Cardiomyopathy. Circulation. 2014;130:1589–1600. doi: 10.1161/CIRCULATIONAHA.114.009847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.009847</ArticleId><ArticleId IdType="pubmed">25165091</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadkarni R., Chu W.C., Lee C.Q.E., Mohamud Y., Yap L., Toh G.A., Beh S., Lim R., Fan Y.M., Zhang Y.L., et al. Viral proteases activate the CARD8 inflammasome in the human cardiovascular system. J. Exp. Med. 2022;219:e20212117. doi: 10.1084/jem.20212117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20212117</ArticleId><ArticleId IdType="pmc">PMC9499823</ArticleId><ArticleId IdType="pubmed">36129453</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbea C., Makar K.A., Pauschinger M., Pratt G., Bersola J.L.F., Varela J., David R.M., Banks L., Huang C.H., Li H., et al. A Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy. J. Biol. Chem. 2010;285:23208–23223. doi: 10.1074/jbc.M109.047464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.047464</ArticleId><ArticleId IdType="pmc">PMC2906314</ArticleId><ArticleId IdType="pubmed">20472559</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature. 2001;413:732–738. doi: 10.1038/35099560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35099560</ArticleId><ArticleId IdType="pubmed">11607032</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen S., Thomsen A.R. Sensing of RNA Viruses: A Review of Innate Immune Receptors Involved in Recognizing RNA Virus Invasion. J. Virol. 2012;86:2900–2910. doi: 10.1128/JVI.05738-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05738-11</ArticleId><ArticleId IdType="pmc">PMC3302314</ArticleId><ArticleId IdType="pubmed">22258243</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou K., Orthopoulos G., Vakakis E., Ahmed M.A.E., Golenbock D.T., Lepper P.M., Triantafilou M. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell. Microbiol. 2005;7:1117–1126. doi: 10.1111/j.1462-5822.2005.00537.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2005.00537.x</ArticleId><ArticleId IdType="pubmed">16008579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumagai Y., Takeuchi O., Akira S. TLR9 as a key receptor for the recognition of DNA. Adv. Drug Deliv. Rev. 2008;60:795–804. doi: 10.1016/j.addr.2007.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2007.12.004</ArticleId><ArticleId IdType="pubmed">18262306</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T., Kawai T. Toll-Like Receptor Signaling Pathways. Front. Immunol. 2014;5:461. doi: 10.3389/fimmu.2014.00461.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00461</ArticleId><ArticleId IdType="pmc">PMC4174766</ArticleId><ArticleId IdType="pubmed">25309543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441:101–105. doi: 10.1038/nature04734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04734</ArticleId><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael Lavigne G., Russell H., Sherry B., Ke R. Autocrine and paracrine interferon signalling as ‘ring vaccination’ and ‘contact tracing’ strategies to suppress virus infection in a host. Proc. R. Soc. B Biol. Sci. 2021;288:20203002. doi: 10.1098/rspb.2020.3002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2020.3002</ArticleId><ArticleId IdType="pmc">PMC7935137</ArticleId><ArticleId IdType="pubmed">33622135</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolgovsky S., Ibeh U., Tamayo T.P., Alcaide P. Adding insult to injury—Inflammation at the heart of cardiac fibrosis. Cell. Signal. 2021;77:109828. doi: 10.1016/j.cellsig.2020.109828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2020.109828</ArticleId><ArticleId IdType="pmc">PMC7718304</ArticleId><ArticleId IdType="pubmed">33166625</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo P.S., Polegato B.F., Minicucci M.F., Paiva S.A.R., Zornoff L.A.M. Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment. Arq. Bras. Cardiol. 2016;106:62–69. doi: 10.5935/abc.20160005.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/abc.20160005</ArticleId><ArticleId IdType="pmc">PMC4728597</ArticleId><ArticleId IdType="pubmed">26647721</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D., Wang P., Yang J., Qian Q., Li M., Wei L., Xu W. Gr-1+ Cells Other Than Ly6G+ Neutrophils Limit Virus Replication and Promote Myocardial Inflammation and Fibrosis Following Coxsackievirus B3 Infection of Mice. Front. Cell. Infect. Microbiol. 2018;8:157. doi: 10.3389/fcimb.2018.00157.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2018.00157</ArticleId><ArticleId IdType="pmc">PMC5962688</ArticleId><ArticleId IdType="pubmed">29868513</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond M.D., Ai Y., Sansing L.H. Gr1+ Macrophages and Dendritic Cells Dominate the Inflammatory Infiltrate 12 h After Experimental Intracerebral Hemorrhage. Transl. Stroke Res. 2012;3:125–131. doi: 10.1007/s12975-012-0174-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12975-012-0174-9</ArticleId><ArticleId IdType="pmc">PMC3524269</ArticleId><ArticleId IdType="pubmed">23259009</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedermeier M., Reich B., Gomez M.R., Denzel A., Schmidbauer K., Göbel N., Talke Y., Schweda F., Mack M. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc. Natl. Acad. Sci. USA. 2009;106:17892–17897. doi: 10.1073/pnas.0906070106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906070106</ArticleId><ArticleId IdType="pmc">PMC2764893</ArticleId><ArticleId IdType="pubmed">19815530</ArticleId></ArticleIdList></Reference><Reference><Citation>Beinert H., Holm R.H., Münck E. Iron-Sulfur Clusters: Nature’s Modular, Multipurpose Structures. Science. 1997;277:653–659. doi: 10.1126/science.277.5326.653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.277.5326.653</ArticleId><ArticleId IdType="pubmed">9235882</ArticleId></ArticleIdList></Reference><Reference><Citation>Naito Y., Tsujino T., Matsumoto M., Sakoda T., Ohyanagi M., Masuyama T. Adaptive response of the heart to long-term anemia induced by iron deficiency. Am. J. Physiol. Heart Circ. Physiol. 2009;296:H585–H593. doi: 10.1152/ajpheart.00463.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00463.2008</ArticleId><ArticleId IdType="pubmed">19136608</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoes M.F., Grote Beverborg N., Kijlstra J.D., Kuipers J., Swinkels D.W., Giepmans B.N.G., Rodenburg R.J., van Veldhuisen D.J., de Boer R.A., van der Meer P. Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function. Eur. J. Heart Fail. 2018;20:910–919. doi: 10.1002/ejhf.1154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1154</ArticleId><ArticleId IdType="pmc">PMC5993224</ArticleId><ArticleId IdType="pubmed">29484788</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobak K.A., Franczuk P., Schubert J., Dzięgała M., Kasztura M., Tkaczyszyn M., Drozd M., Kosiorek A., Kiczak L., Bania J., et al. Primary Human Cardiomyocytes and Cardiofibroblasts Treated with Sera from Myocarditis Patients Exhibit an Increased Iron Demand and Complex Changes in the Gene Expression. Cells. 2021;10:818. doi: 10.3390/cells10040818.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10040818</ArticleId><ArticleId IdType="pmc">PMC8067399</ArticleId><ArticleId IdType="pubmed">33917391</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelosi E., Testa U., Louache F., Thomopoulos P., Salvo G., Samoggia P., Peschle C. Expression of transferrin receptors in phytohemagglutinin-stimulated human T-lymphocytes. Evidence for a three-step model. J. Biol. Chem. 1986;261:3036–3042. doi: 10.1016/S0021-9258(17)35742-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)35742-3</ArticleId><ArticleId IdType="pubmed">3005277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanser L., Nemati N., Seifert M., Fuchs D., Weiss G., Pölzl G., Kurz K. Inflammation, iron and vitamin D metabolism in different cardiomyopathy aetiologies. Pteridines. 2020;31:28–37. doi: 10.1515/pteridines-2020-0004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/pteridines-2020-0004</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Cao F., Yin H., Huang Z., Lin Z., Mao N., Sun B., Wang G. Ferroptosis: Past, present and future. Cell Death Dis. 2020;11:88. doi: 10.1038/s41419-020-2298-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2298-2</ArticleId><ArticleId IdType="pmc">PMC6997353</ArticleId><ArticleId IdType="pubmed">32015325</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L., Hu Y., Wu Z., Li Y., Kong M., Kang Z., Zuoyuan B., Yang Z. TFRC upregulation promotes ferroptosis in CVB3 infection via nucleus recruitment of Sp1. Cell Death Dis. 2022;13:592. doi: 10.1038/s41419-022-05027-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-05027-w</ArticleId><ArticleId IdType="pmc">PMC9276735</ArticleId><ArticleId IdType="pubmed">35821227</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong M., Rong J., Tao X., Xu Y. The Emerging Role of Ferroptosis in Cardiovascular Diseases. Front. Pharmacol. 2022;13:822083. doi: 10.3389/fphar.2022.822083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.822083</ArticleId><ArticleId IdType="pmc">PMC8826236</ArticleId><ArticleId IdType="pubmed">35153792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursu O.N., Sauter M., Ettischer N., Kandolf R., Klingel K. Heme Oxygenase-1 Mediates Oxidative Stress and Apoptosis in Coxsackievirus B3-Induced Myocarditis. Cell. Physiol. Biochem. 2014;33:52–66. doi: 10.1159/000356649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000356649</ArticleId><ArticleId IdType="pubmed">24401606</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Li M., Chen Z., Yu Y., Shi H., Yu Y., Wang Y., Chen R., Ge J. Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis. Basic Res. Cardiol. 2022;117:40. doi: 10.1007/s00395-022-00948-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-022-00948-1</ArticleId><ArticleId IdType="pmc">PMC9399059</ArticleId><ArticleId IdType="pubmed">35997820</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Yu Y., Liu X., Yu Y., Li M., Wang Y., Zou Y., Chen R., Ge J. Inhibition of calpain reduces cell apoptosis by suppressing mitochondrial fission in acute viral myocarditis. Cell Biol. Toxicol. 2022;38:487–504. doi: 10.1007/s10565-021-09634-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10565-021-09634-9</ArticleId><ArticleId IdType="pmc">PMC9200683</ArticleId><ArticleId IdType="pubmed">34365571</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh S.-J., Lim B.-K., Yun J., Shin O.S. CVB3-Mediated Mitophagy Plays an Important Role in Viral Replication via Abrogation of Interferon Pathways. Front. Cell. Infect. Microbiol. 2021;11:704494. doi: 10.3389/fcimb.2021.704494.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.704494</ArticleId><ArticleId IdType="pmc">PMC8292102</ArticleId><ArticleId IdType="pubmed">34295842</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin J., McIntyre L., Stotland A., Feuer R., Gottlieb R.A. Coxsackievirus B Escapes the Infected Cell in Ejected Mitophagosomes. J. Virol. 2017;91:e01347-17. doi: 10.1128/JVI.01347-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01347-17</ArticleId><ArticleId IdType="pmc">PMC5709598</ArticleId><ArticleId IdType="pubmed">28978702</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu L., Wang H., Hou P., Guo S., He M., Xiao J., Li P., Zhong Y., Jia P., Cao Y., et al. The Ubiquitin E3 Ligase Parkin Inhibits Innate Antiviral Immunity Through K48-Linked Polyubiquitination of RIG-I and MDA5. Front. Immunol. 2020;11:1926. doi: 10.3389/fimmu.2020.01926.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01926</ArticleId><ArticleId IdType="pmc">PMC7492610</ArticleId><ArticleId IdType="pubmed">32983119</ArticleId></ArticleIdList></Reference><Reference><Citation>Remels A.H.V., Derks W.J.A., Cillero-Pastor B., Verhees K.J.P., Kelders M.C., Heggermont W., Carai P., Summer G., Ellis S.R., de Theije C.C., et al. NF-κB-mediated metabolic remodelling in the inflamed heart in acute viral myocarditis. Biochim. Biophys. Acta BBA Mol. Basis Dis. 2018;1864:2579–2589. doi: 10.1016/j.bbadis.2018.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2018.04.022</ArticleId><ArticleId IdType="pubmed">29730342</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher R.P., Clayton D.A. Purification and characterization of human mitochondrial transcription factor 1. Mol. Cell. Biol. 1988;8:3496–3509. doi: 10.1128/mcb.8.8.3496-3509.1988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.8.8.3496-3509.1988</ArticleId><ArticleId IdType="pmc">PMC363587</ArticleId><ArticleId IdType="pubmed">3211148</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson N.-G., Wang J., Wilhelmsson H., Oldfors A., Rustin P., Lewandoski M., Barsh G.S., Clayton D.A. Mitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in mice. Nat. Genet. 1998;18:231–236. doi: 10.1038/ng0398-231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0398-231</ArticleId><ArticleId IdType="pubmed">9500544</ArticleId></ArticleIdList></Reference><Reference><Citation>LeBleu V.S., O’Connell J.T., Herrera K.N.G., Wikman-Kocher H., Pantel K., Haigis M.C., de Carvalho F.M., Damascena A., Chinen L.T.D., Rocha R.M., et al. PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation to promote metastasis. Nat. Cell Biol. 2014;16:992–1003. doi: 10.1038/ncb3039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3039</ArticleId><ArticleId IdType="pmc">PMC4369153</ArticleId><ArticleId IdType="pubmed">25241037</ArticleId></ArticleIdList></Reference><Reference><Citation>Dassanayaka S., Jones S.P. O-GlcNAc and the cardiovascular system. Pharmacol. Ther. 2014;142:62–71. doi: 10.1016/j.pharmthera.2013.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2013.11.005</ArticleId><ArticleId IdType="pmc">PMC3943723</ArticleId><ArticleId IdType="pubmed">24287310</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradies G., Paradies V., Ruggiero F.M., Petrosillo G. Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J. Gastroenterol. WJG. 2014;20:14205–14218. doi: 10.3748/wjg.v20.i39.14205.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v20.i39.14205</ArticleId><ArticleId IdType="pmc">PMC4202349</ArticleId><ArticleId IdType="pubmed">25339807</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies P., Bailey P.J., Goldenberg M.M., Ford-Hutchinson A.W. The Role of Arachidonic Acid Oxygenation Products in Pain and Inflammation. Annu. Rev. Immunol. 1984;2:335–357. doi: 10.1146/annurev.iy.02.040184.002003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.iy.02.040184.002003</ArticleId><ArticleId IdType="pubmed">6100476</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang H., Judd R.L. Comprehensive Physiology. John Wiley &amp; Sons, Ltd.; Hoboken, NJ, USA: 2018. Adiponectin regulation and function; pp. 1031–1063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c170046</ArticleId><ArticleId IdType="pubmed">29978896</ArticleId></ArticleIdList></Reference><Reference><Citation>Skurk C., Wittchen F., Suckau L., Witt H., Noutsias M., Fechner H., Schultheiss H.-P., Poller W. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Eur. Heart J. 2008;29:1168–1180. doi: 10.1093/eurheartj/ehn136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehn136</ArticleId><ArticleId IdType="pubmed">18390538</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenke A., Holzhauser L., Löbel M., Savvatis K., Wilk S., Weithäuser A., Pinkert S., Tschöpe C., Klingel K., Poller W., et al. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses. Basic Res. Cardiol. 2014;109:408. doi: 10.1007/s00395-014-0408-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-014-0408-y</ArticleId><ArticleId IdType="pubmed">24691762</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisancho-Kiss S., Nyland J.F., Davis S.E., Augusto Frisancho J., Barrett M.A., Rose N.R., Fairweather D. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rβ1 signaling and IFN-γ increase inflammation in males independent from STAT4. Brain Res. 2006;1126:139–147. doi: 10.1016/j.brainres.2006.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2006.08.003</ArticleId><ArticleId IdType="pubmed">16949558</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Yusung S., Frisancho S., Barrett M., Gatewood S., Steele R., Rose N.R. IL-12 Receptor β1 and Toll-Like Receptor 4 Increase IL-1β- and IL-18-Associated Myocarditis and Coxsackievirus Replication. J. Immunol. 2003;170:4731–4737. doi: 10.4049/jimmunol.170.9.4731.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.9.4731</ArticleId><ArticleId IdType="pubmed">12707353</ArticleId></ArticleIdList></Reference><Reference><Citation>Cihakova D., Barin J.G., Afanasyeva M., Kimura M., Fairweather D., Berg M., Talor M.V., Baldeviano G.C., Frisancho S., Gabrielson K., et al. Interleukin-13 Protects Against Experimental Autoimmune Myocarditis by Regulating Macrophage Differentiation. Am. J. Pathol. 2008;172:1195–1208. doi: 10.2353/ajpath.2008.070207.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.070207</ArticleId><ArticleId IdType="pmc">PMC2329830</ArticleId><ArticleId IdType="pubmed">18403598</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J.-M., Bothwell A.L.M. The Nuclear Receptor PPARs as Important Regulators of T-Cell Functions and Autoimmune Diseases. Mol. Cells. 2012;33:217–222. doi: 10.1007/s10059-012-2297-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10059-012-2297-y</ArticleId><ArticleId IdType="pmc">PMC3887706</ArticleId><ArticleId IdType="pubmed">22382683</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H., Zhao F., Xie X., Liao Y., Song Y., Liu C., Wu Y., Wang Y., Liu D., Wang Y., et al. PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis. Exp. Cell Res. 2019;375:22–30. doi: 10.1016/j.yexcr.2018.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.12.005</ArticleId><ArticleId IdType="pubmed">30557558</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L., Lopes J.E., Chong M.M.W., Ivanov I.I., Min R., Victora G.D., Shen Y., Du J., Rubtsov Y.P., Rudensky A.Y., et al. TGF-β-induced Foxp3 inhibits Th17 cell differentiation by antagonizing RORγt function. Nature. 2008;453:236–240. doi: 10.1038/nature06878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06878</ArticleId><ArticleId IdType="pmc">PMC2597437</ArticleId><ArticleId IdType="pubmed">18368049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten S., Desvergne B., Wahli W. Roles of PPARs in health and disease. Nature. 2000;405:421–424. doi: 10.1038/35013000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35013000</ArticleId><ArticleId IdType="pubmed">10839530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan H.W.S., Anjum B., Shen H.-M., Ghosh S., Yen P.M., Sinha R.A. Lysosomal inhibition attenuates peroxisomal gene transcription via suppression of PPARA and PPARGC1A levels. Autophagy. 2019;15:1455–1459. doi: 10.1080/15548627.2019.1609847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1609847</ArticleId><ArticleId IdType="pmc">PMC6613898</ArticleId><ArticleId IdType="pubmed">31032705</ArticleId></ArticleIdList></Reference><Reference><Citation>Handschin C., Spiegelman B.M. Peroxisome Proliferator-Activated Receptor γ Coactivator 1 Coactivators, Energy Homeostasis, and Metabolism. Endocr. Rev. 2006;27:728–735. doi: 10.1210/er.2006-0037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2006-0037</ArticleId><ArticleId IdType="pubmed">17018837</ArticleId></ArticleIdList></Reference><Reference><Citation>Riehle C., Wende A.R., Zaha V.G., Pires K.M., Wayment B., Olsen C., Bugger H., Buchanan J., Wang X., Moreira A.B., et al. PGC-1β Deficiency Accelerates the Transition to Heart Failure in Pressure Overload Hypertrophy. Circ. Res. 2011;109:783–793. doi: 10.1161/CIRCRESAHA.111.243964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.111.243964</ArticleId><ArticleId IdType="pmc">PMC3175248</ArticleId><ArticleId IdType="pubmed">21799152</ArticleId></ArticleIdList></Reference><Reference><Citation>Arany Z., Novikov M., Chin S., Ma Y., Rosenzweig A., Spiegelman B.M. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-γ coactivator 1α. Proc. Natl. Acad. Sci. USA. 2006;103:10086–10091. doi: 10.1073/pnas.0603615103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603615103</ArticleId><ArticleId IdType="pmc">PMC1502510</ArticleId><ArticleId IdType="pubmed">16775082</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Zhang L., Yu C., Yang X.-F., Wang H. Monocyte and macrophage differentiation: Circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark. Res. 2014;2:1. doi: 10.1186/2050-7771-2-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2050-7771-2-1</ArticleId><ArticleId IdType="pmc">PMC3892095</ArticleId><ArticleId IdType="pubmed">24398220</ArticleId></ArticleIdList></Reference><Reference><Citation>Golubovskaya V., Wu L. Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy. Cancers. 2016;8:36. doi: 10.3390/cancers8030036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers8030036</ArticleId><ArticleId IdType="pmc">PMC4810120</ArticleId><ArticleId IdType="pubmed">26999211</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson S.M., Wilson P.C., James J.A., Capra J.D. Advances in Immunology. Academic Press; Cambridge, MA, USA: 2008. Human B cell subsets; pp. 151–224. Chapter 5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-2776(08)00405-7</ArticleId><ArticleId IdType="pubmed">18772006</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKenna D., Summerour S.R., Villarreal F.J. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc. Res. 2000;46:257–263. doi: 10.1016/S0008-6363(00)00030-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-6363(00)00030-4</ArticleId><ArticleId IdType="pubmed">10773229</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Yue Y., Xiong S. Dpep2 Emerging as a Modulator of Macrophage Inflammation Confers Protection Against CVB3-Induced Viral Myocarditis. Front. Cell. Infect. Microbiol. 2019;9:57. doi: 10.3389/fcimb.2019.00057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00057</ArticleId><ArticleId IdType="pmc">PMC6416667</ArticleId><ArticleId IdType="pubmed">30899700</ArticleId></ArticleIdList></Reference><Reference><Citation>Carai P., Ruozi G., Paye A., Debing Y., Bortolotti F., Lecomte J., Zentilin L., Jones E.A.V., Giacca M., Heymans S. AAV9-mediated functional screening for cardioprotective cytokines in Coxsackievirus-B3-induced myocarditis. Sci. Rep. 2022;12:7304. doi: 10.1038/s41598-022-11131-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-11131-w</ArticleId><ArticleId IdType="pmc">PMC9067557</ArticleId><ArticleId IdType="pubmed">35508525</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M., Long Q., Li H.-H., Liang W., Liao Y.-H., Yuan J., Cheng X. IL-9 Inhibits Viral Replication in Coxsackievirus B3-Induced Myocarditis. Front. Immunol. 2016;7:409. doi: 10.3389/fimmu.2016.00409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00409</ArticleId><ArticleId IdType="pmc">PMC5052262</ArticleId><ArticleId IdType="pubmed">27766098</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhingra S., Sharma A.K., Arora R.C., Slezak J., Singal P.K. IL-10 attenuates TNF-α-induced NFκB pathway activation and cardiomyocyte apoptosis. Cardiovasc. Res. 2009;82:59–66. doi: 10.1093/cvr/cvp040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvp040</ArticleId><ArticleId IdType="pubmed">19181934</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 2002;23:144–150. doi: 10.1016/S1471-4906(01)02154-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1471-4906(01)02154-8</ArticleId><ArticleId IdType="pubmed">11864843</ArticleId></ArticleIdList></Reference><Reference><Citation>YlÖstalo J.H., Bartosh T.J., Coble K., Prockop D.J. Human Mesenchymal Stem/Stromal Cells Cultured as Spheroids are Self-activated to Produce Prostaglandin E2 that Directs Stimulated Macrophages into an Anti-inflammatory Phenotype. Stem Cells. 2012;30:2283–2296. doi: 10.1002/stem.1191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1191</ArticleId><ArticleId IdType="pmc">PMC3448872</ArticleId><ArticleId IdType="pubmed">22865689</ArticleId></ArticleIdList></Reference><Reference><Citation>Loynes C.A., Lee J.A., Robertson A.L., Steel M.J.G., Ellett F., Feng Y., Levy B.D., Whyte M.K.B., Renshaw S.A. PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo. Sci. Adv. 2018;4:eaar8320. doi: 10.1126/sciadv.aar8320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aar8320</ArticleId><ArticleId IdType="pmc">PMC6124908</ArticleId><ArticleId IdType="pubmed">30191175</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Cao Y., Tian Y., Gu Y., Lu H., Zhang S., Xu H., Su Z. PGE2 ameliorated viral myocarditis development and promoted IL-10-producing regulatory B cell expansion via MAPKs/AKT-AP1 axis or AhR signaling. Cell. Immunol. 2020;347:104025. doi: 10.1016/j.cellimm.2019.104025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2019.104025</ArticleId><ArticleId IdType="pubmed">31837749</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Li L., Xiao L., Shangguan J. Progranulin ameliorates coxsackievirus-B3-induced viral myocarditis by downregulating Th1 and Th17 cells. Exp. Cell Res. 2018;367:241–250. doi: 10.1016/j.yexcr.2018.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.04.001</ArticleId><ArticleId IdType="pubmed">29625085</ArticleId></ArticleIdList></Reference><Reference><Citation>Carai P., Papageorgiou A.P., Van Linthout S., Deckx S., Velthuis S., Lutgens E., Wijnands E., Tschöpe C., Schmuttermaier C., Kzhyshkowska J., et al. Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis. J. Mol. Cell. Cardiol. 2022;165:31–39. doi: 10.1016/j.yjmcc.2021.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2021.12.009</ArticleId><ArticleId IdType="pubmed">34968453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratofil R.M., Kubes P., Deniset J.F. Monocyte Conversion During Inflammation and Injury. Arterioscler. Thromb. Vasc. Biol. 2017;37:35–42. doi: 10.1161/ATVBAHA.116.308198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.116.308198</ArticleId><ArticleId IdType="pubmed">27765768</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuschner F., Courties G., Dutta P., Mortensen L.J., Gorbatov R., Sena B., Novobrantseva T.I., Borodovsky A., Fitzgerald K., Koteliansky V., et al. Silencing of CCR2 in myocarditis. Eur. Heart J. 2015;36:1478–1488. doi: 10.1093/eurheartj/ehu225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu225</ArticleId><ArticleId IdType="pmc">PMC4465633</ArticleId><ArticleId IdType="pubmed">24950695</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou C.-L., Peters W., Si Y., Slaymaker S., Aslanian A.M., Weisberg S.P., Mack M., Charo I.F. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Investig. 2007;117:902–909. doi: 10.1172/JCI29919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI29919</ArticleId><ArticleId IdType="pmc">PMC1810572</ArticleId><ArticleId IdType="pubmed">17364026</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Li Y., Wei B., Wu W., Gao X. CD80 Regulates Th17 Cell Differentiation in Coxsackie Virus B3-Induced Acute Myocarditis. Inflammation. 2018;41:232–239. doi: 10.1007/s10753-017-0681-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-017-0681-7</ArticleId><ArticleId IdType="pubmed">29039143</ArticleId></ArticleIdList></Reference><Reference><Citation>De Giusti C.J., Ure A.E., Rivadeneyra L., Schattner M., Gomez R.M. Macrophages and galectin 3 play critical roles in CVB3-induced murine acute myocarditis and chronic fibrosis. J. Mol. Cell. Cardiol. 2015;85:58–70. doi: 10.1016/j.yjmcc.2015.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2015.05.010</ArticleId><ArticleId IdType="pubmed">26002282</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers J.M., Cooper L.T., Kem D.C., Stavrakis S., Kosanke S.D., Shevach E.M., Fairweather D., Stoner J.A., Cox C.J., Cunningham M.W. Cardiac myosin-Th17 responses promote heart failure in human myocarditis. JCI Insight. 2016;1:e85851. doi: 10.1172/jci.insight.85851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.85851</ArticleId><ArticleId IdType="pmc">PMC4924810</ArticleId><ArticleId IdType="pubmed">27366791</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeachy M.J. GM-CSF: The secret weapon in the TH17 arsenal. Nat. Immunol. 2011;12:521–522. doi: 10.1038/ni.2044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2044</ArticleId><ArticleId IdType="pubmed">21587311</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldeviano G.C., Barin J.G., Talor M.V., Srinivasan S., Bedja D., Zheng D., Gabrielson K., Iwakura Y., Rose N.R., Cihakova D. Interleukin-17A Is Dispensable for Myocarditis but Essential for the Progression to Dilated Cardiomyopathy. Circ. Res. 2010;106:1646–1655. doi: 10.1161/CIRCRESAHA.109.213157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.109.213157</ArticleId><ArticleId IdType="pubmed">20378858</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraft L., Erdenesukh T., Sauter M., Tschöpe C., Klingel K. Blocking the IL-1β signalling pathway prevents chronic viral myocarditis and cardiac remodeling. Basic Res. Cardiol. 2019;114:11. doi: 10.1007/s00395-019-0719-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-019-0719-0</ArticleId><ArticleId IdType="pubmed">30673858</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kofahi M., Omura S., Tsunoda I., Sato F., Becker F., Gavins F.N., Woolard M.D., Pattillo C., Zawieja D., Muthuchamy M., et al. IL-1β reduces cardiac lymphatic muscle contraction via COX-2 and PGE2 induction: Potential role in myocarditis. Biomed. Pharmacother. 2018;107:1591–1600. doi: 10.1016/j.biopha.2018.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.08.004</ArticleId><ArticleId IdType="pubmed">30257377</ArticleId></ArticleIdList></Reference><Reference><Citation>Savvatis K., Müller I., Fröhlich M., Pappritz K., Zietsch C., Hamdani N., Grote K., Schieffer B., Klingel K., Van Linthout S., et al. Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis. Basic Res. Cardiol. 2014;109:449. doi: 10.1007/s00395-014-0449-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-014-0449-2</ArticleId><ArticleId IdType="pubmed">25344085</ArticleId></ArticleIdList></Reference><Reference><Citation>Valaperti A., Nishii M., Liu Y., Naito K., Chan M., Zhang L., Skurk C., Schultheiss H.-P., Wells G.A., Eriksson U., et al. Innate Immune Interleukin-1 Receptor–Associated Kinase 4 Exacerbates Viral Myocarditis by Reducing CCR5+CD11b+ Monocyte Migration and Impairing Interferon Production. Circulation. 2013;128:1542–1554. doi: 10.1161/CIRCULATIONAHA.113.002275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.002275</ArticleId><ArticleId IdType="pubmed">24030499</ArticleId></ArticleIdList></Reference><Reference><Citation>López B., González A., Lindner D., Westermann D., Ravassa S., Beaumont J., Gallego I., Zudaire A., Brugnolaro C., Querejeta R., et al. Osteopontin-mediated myocardial fibrosis in heart failure: A role for lysyl oxidase? Cardiovasc. Res. 2013;99:111–120. doi: 10.1093/cvr/cvt100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvt100</ArticleId><ArticleId IdType="pubmed">23619422</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniak S., Owens A.P., III, Baunacke M., Williams J.C., Lee R.D., Weithäuser A., Sheridan P.A., Malz R., Luyendyk J.P., Esserman D.A., et al. PAR-1 contributes to the innate immune response during viral infection. J. Clin. Investig. 2013;123:1310–1322. doi: 10.1172/JCI66125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI66125</ArticleId><ArticleId IdType="pmc">PMC3582138</ArticleId><ArticleId IdType="pubmed">23391721</ArticleId></ArticleIdList></Reference><Reference><Citation>Weithauser A., Bobbert P., Antoniak S., Böhm A., Rauch B.H., Klingel K., Savvatis K., Kroemer H.K., Tschope C., Stroux A., et al. Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B3–Induced Myocarditis. J. Am. Coll. Cardiol. 2013;62:1737–1745. doi: 10.1016/j.jacc.2013.05.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.05.076</ArticleId><ArticleId IdType="pmc">PMC4077621</ArticleId><ArticleId IdType="pubmed">23871888</ArticleId></ArticleIdList></Reference><Reference><Citation>Müller I., Vogl T., Pappritz K., Miteva K., Savvatis K., Rohde D., Most P., Lassner D., Pieske B., Kühl U., et al. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3–Induced Myocarditis. Circ. Heart Fail. 2017;10:e004125. doi: 10.1161/CIRCHEARTFAILURE.117.004125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.117.004125</ArticleId><ArticleId IdType="pubmed">29158436</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Chen B., Yang X., Zhang C., Jiao Y., Li P., Liu Y., Li Z., Qiao B., Bond Lau W., et al. S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury. Circulation. 2019;140:751–764. doi: 10.1161/CIRCULATIONAHA.118.039262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.039262</ArticleId><ArticleId IdType="pubmed">31220942</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y.-L., Zhang S.-X., Zheng C.-F., Li Y.-F., Zhang L.-H., Hao Y.-F., Wang S., Li X.-W. Silencing of STAT4 Protects Against Autoimmune Myocarditis by Regulating Th1/Th2 Immune Response via Inactivation of the NF-κB Pathway in Rats. Inflammation. 2019;42:1179–1189. doi: 10.1007/s10753-019-00978-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-019-00978-3</ArticleId><ArticleId IdType="pubmed">30848408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya S., Wang W., Morales-Nebreda L., Feng G., Wu M., Zhou X., Lafyatis R., Lee J., Hinchcliff M., Feghali-Bostwick C., et al. Tenascin-C drives persistence of organ fibrosis. Nat. Commun. 2016;7:11703. doi: 10.1038/ncomms11703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11703</ArticleId><ArticleId IdType="pmc">PMC4895803</ArticleId><ArticleId IdType="pubmed">27256716</ArticleId></ArticleIdList></Reference><Reference><Citation>Juni R.P., Kuster D.W.D., Goebel M., Helmes M., Musters R.J.P., van der Velden J., Koolwijk P., Paulus W.J., van Hinsbergh V.W.M. Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin. JACC Basic Transl. Sci. 2019;4:575–591. doi: 10.1016/j.jacbts.2019.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2019.04.003</ArticleId><ArticleId IdType="pmc">PMC6872802</ArticleId><ArticleId IdType="pubmed">31768475</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M., Chen M., Dawood F., Zurawska U., Li J.Y., Parker T., Kassiri Z., Kirshenbaum L.A., Arnold M., Khokha R., et al. Tumor Necrosis Factor-α Mediates Cardiac Remodeling and Ventricular Dysfunction After Pressure Overload State. Circulation. 2007;115:1398–1407. doi: 10.1161/CIRCULATIONAHA.106.643585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.643585</ArticleId><ArticleId IdType="pubmed">17353445</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S.A., Sartini D. Roles of Tumor Necrosis Factor Alpha (TNF-α) and the p55 TNF Receptor in CD1d Induction and Coxsackievirus B3-Induced Myocarditis. J. Virol. 2005;79:2659–2665. doi: 10.1128/JVI.79.5.2659-2665.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.5.2659-2665.2005</ArticleId><ArticleId IdType="pmc">PMC548425</ArticleId><ArticleId IdType="pubmed">15708985</ArticleId></ArticleIdList></Reference><Reference><Citation>Suematsu N., Tsutsui H., Wen J., Kang D., Ikeuchi M., Ide T., Hayashidani S., Shiomi T., Kubota T., Hamasaki N., et al. Oxidative Stress Mediates Tumor Necrosis Factor-α–Induced Mitochondrial DNA Damage and Dysfunction in Cardiac Myocytes. Circulation. 2003;107:1418–1423. doi: 10.1161/01.CIR.0000055318.09997.1F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000055318.09997.1F</ArticleId><ArticleId IdType="pubmed">12642364</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M., Zhang A., Du Y., Lu W., Wang J., Minze L.J., Cox T.C., Li X.C., Xing J., Zhang Z. TRIM18 is a critical regulator of viral myocarditis and organ inflammation. J. Biomed. Sci. 2022;29:55. doi: 10.1186/s12929-022-00840-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-022-00840-z</ArticleId><ArticleId IdType="pmc">PMC9339186</ArticleId><ArticleId IdType="pubmed">35909127</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasrado N., Borcherding N., Arumugam R., Starr T.K., Reddy J. Dissecting the cellular landscape and transcriptome network in viral myocarditis by single-cell RNA sequencing. IScience. 2022;25:103865. doi: 10.1016/j.isci.2022.103865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.103865</ArticleId><ArticleId IdType="pmc">PMC8861636</ArticleId><ArticleId IdType="pubmed">35243228</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes B.J., Field A.E., Pitha-Rowe P.M. Virus-induced Heterodimer Formation betweenIRF-5 and IRF-7 Modulates Assembly of theIFNA Enhanceosome in Vivo and Transcriptional Activity of IFNA Genes. J. Biol. Chem. 2003;278:16630–16641. doi: 10.1074/jbc.M212609200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M212609200</ArticleId><ArticleId IdType="pubmed">12600985</ArticleId></ArticleIdList></Reference><Reference><Citation>Garlanda C., Dinarello C.A., Mantovani A. The Interleukin-1 Family: Back to the Future. Immunity. 2013;39:1003–1018. doi: 10.1016/j.immuni.2013.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.11.010</ArticleId><ArticleId IdType="pmc">PMC3933951</ArticleId><ArticleId IdType="pubmed">24332029</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarello C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117:3720–3732. doi: 10.1182/blood-2010-07-273417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-07-273417</ArticleId><ArticleId IdType="pmc">PMC3083294</ArticleId><ArticleId IdType="pubmed">21304099</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson N.C., Mackinnon A.C., Farnworth S.L., Poirier F., Russo F.P., Iredale J.P., Haslett C., Simpson K.J., Sethi T. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc. Natl. Acad. Sci. USA. 2006;103:5060–5065. doi: 10.1073/pnas.0511167103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0511167103</ArticleId><ArticleId IdType="pmc">PMC1458794</ArticleId><ArticleId IdType="pubmed">16549783</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma U., Rhaleb N.-E., Pokharel S., Harding P., Rasoul S., Peng H., Carretero O.A. Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage. Am. J. Physiol. Heart Circ. Physiol. 2008;294:H1226–H1232. doi: 10.1152/ajpheart.00305.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00305.2007</ArticleId><ArticleId IdType="pmc">PMC6824420</ArticleId><ArticleId IdType="pubmed">18178715</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D., Han Z., Oppenheim J.J. Alarmins and immunity. Immunol. Rev. 2017;280:41–56. doi: 10.1111/imr.12577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12577</ArticleId><ArticleId IdType="pmc">PMC5699517</ArticleId><ArticleId IdType="pubmed">29027222</ArticleId></ArticleIdList></Reference><Reference><Citation>Rider P., Voronov E., Dinarello C.A., Apte R.N., Cohen I. Alarmins: Feel the Stress. J. Immunol. 2017;198:1395–1402. doi: 10.4049/jimmunol.1601342.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601342</ArticleId><ArticleId IdType="pubmed">28167650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Song R., Wang Z., Jing Z., Wang S., Ma J. S100A8/A9 in Inflammation. Front. Immunol. 2018;9:1298. doi: 10.3389/fimmu.2018.01298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01298</ArticleId><ArticleId IdType="pmc">PMC6004386</ArticleId><ArticleId IdType="pubmed">29942307</ArticleId></ArticleIdList></Reference><Reference><Citation>Averill M.M., Kerkhoff C., Bornfeldt K.E. S100A8 and S100A9 in Cardiovascular Biology and Disease. Arterioscler. Thromb. Vasc. Biol. 2012;32:223–229. doi: 10.1161/ATVBAHA.111.236927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.111.236927</ArticleId><ArticleId IdType="pmc">PMC3262097</ArticleId><ArticleId IdType="pubmed">22095980</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Anholts J., Kolbe U., Stegehuis-Kamp J.A., Claas F.H.J., Eikmans M. Calcium-Binding Proteins S100A8 and S100A9: Investigation of Their Immune Regulatory Effect in Myeloid Cells. Int. J. Mol. Sci. 2018;19:1833. doi: 10.3390/ijms19071833.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19071833</ArticleId><ArticleId IdType="pmc">PMC6073713</ArticleId><ArticleId IdType="pubmed">29933628</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe L.A.N., McLean M., Kitson S.M., Melchor E.G., Patommel K., Cao H.M., Reilly J.H., Leach W.J., Rooney B.P., Spencer S.J., et al. S100A8 &amp; S100A9: Alarmin mediated inflammation in tendinopathy. Sci. Rep. 2019;9:1463. doi: 10.1038/s41598-018-37684-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-37684-3</ArticleId><ArticleId IdType="pmc">PMC6365574</ArticleId><ArticleId IdType="pubmed">30728384</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q., Zhao Y., Li J., Liu J., Yang X., Guo X., Kuang M., Xia H., Zhang Z., Cao L., et al. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19. Cell Host Microbe. 2021;29:222–235.e4. doi: 10.1016/j.chom.2020.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.12.016</ArticleId><ArticleId IdType="pmc">PMC7762710</ArticleId><ArticleId IdType="pubmed">33388094</ArticleId></ArticleIdList></Reference><Reference><Citation>Szalay G., Sauter M., Hald J., Weinzierl A., Kandolf R., Klingel K. Sustained Nitric Oxide Synthesis Contributes to Immunopathology in Ongoing Myocarditis Attributable to Interleukin-10 Disorders. Am. J. Pathol. 2006;169:2085–2093. doi: 10.2353/ajpath.2006.060350.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2006.060350</ArticleId><ArticleId IdType="pmc">PMC1762471</ArticleId><ArticleId IdType="pubmed">17148671</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreejit G., Abdel-Latif A., Athmanathan B., Annabathula R., Dhyani A., Noothi S.K., Quaife-Ryan G.A., Al-Sharea A., Pernes G., Dragoljevic D., et al. Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction. Circulation. 2020;141:1080–1094. doi: 10.1161/CIRCULATIONAHA.119.043833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.043833</ArticleId><ArticleId IdType="pmc">PMC7122461</ArticleId><ArticleId IdType="pubmed">31941367</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller O., Stertz S., Kochs G. The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect. 2007;9:1636–1643. doi: 10.1016/j.micinf.2007.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2007.09.010</ArticleId><ArticleId IdType="pubmed">18062906</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang S.-M., Sharma G., Verma R., Byun S., Rudra D., Im S.-H. Inflammation-induced Id2 promotes plasticity in regulatory T cells. Nat. Commun. 2018;9:4736. doi: 10.1038/s41467-018-07254-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07254-2</ArticleId><ArticleId IdType="pmc">PMC6226514</ArticleId><ArticleId IdType="pubmed">30413714</ArticleId></ArticleIdList></Reference><Reference><Citation>Gassner F.J., Zaborsky N., Catakovic K., Rebhandl S., Huemer M., Egle A., Hartmann T.N., Greil R., Geisberger R. Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model. Br. J. Haematol. 2015;170:515–522. doi: 10.1111/bjh.13467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.13467</ArticleId><ArticleId IdType="pmc">PMC4687418</ArticleId><ArticleId IdType="pubmed">25940792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng S.S., De Labastida Rivera F., Yan J., Corvino D., Das I., Zhang P., Kuns R., Chauhan S.B., Hou J., Li X.-Y., et al. The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation. Nat. Immunol. 2020;21:1205–1218. doi: 10.1038/s41590-020-0758-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0758-6</ArticleId><ArticleId IdType="pmc">PMC7965849</ArticleId><ArticleId IdType="pubmed">32839608</ArticleId></ArticleIdList></Reference><Reference><Citation>Basavalingappa R.H., Arumugam R., Lasrado N., Yalaka B., Massilamany C., Gangaplara A., Riethoven J.-J., Xiang S.-H., Steffen D., Reddy J. Viral myocarditis involves the generation of autoreactive T cells with multiple antigen specificities that localize in lymphoid and non-lymphoid organs in the mouse model of CVB3 infection. Mol. Immunol. 2020;124:218–228. doi: 10.1016/j.molimm.2020.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2020.06.017</ArticleId><ArticleId IdType="pmc">PMC7363587</ArticleId><ArticleId IdType="pubmed">32615275</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunte K., Beikler T. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases. Int. J. Mol. Sci. 2019;20:3394. doi: 10.3390/ijms20143394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20143394</ArticleId><ArticleId IdType="pmc">PMC6679067</ArticleId><ArticleId IdType="pubmed">31295952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura A., Kishimoto T. IL-6: Regulator of Treg/Th17 balance. Eur. J. Immunol. 2010;40:1830–1835. doi: 10.1002/eji.201040391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201040391</ArticleId><ArticleId IdType="pubmed">20583029</ArticleId></ArticleIdList></Reference><Reference><Citation>Kara E.E., McKenzie D.R., Bastow C.R., Gregor C.E., Fenix K.A., Ogunniyi A.D., Paton J.C., Mack M., Pombal D.R., Seillet C., et al. CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells. Nat. Commun. 2015;6:8644. doi: 10.1038/ncomms9644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9644</ArticleId><ArticleId IdType="pmc">PMC4639903</ArticleId><ArticleId IdType="pubmed">26511769</ArticleId></ArticleIdList></Reference><Reference><Citation>Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., Mann D.L. Cytokines and Cytokine Receptors in Advanced Heart Failure. Circulation. 2001;103:2055–2059. doi: 10.1161/01.CIR.103.16.2055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.103.16.2055</ArticleId><ArticleId IdType="pubmed">11319194</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd C.E., Taylor A., Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol. Rev. 2009;229:12–26. doi: 10.1111/j.1600-065X.2009.00770.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2009.00770.x</ArticleId><ArticleId IdType="pmc">PMC4186963</ArticleId><ArticleId IdType="pubmed">19426212</ArticleId></ArticleIdList></Reference><Reference><Citation>Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009;27:485–517. doi: 10.1146/annurev.immunol.021908.132710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.021908.132710</ArticleId><ArticleId IdType="pubmed">19132915</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh M., Nakamura M., Saitoh H., Satoh H., Maesawa C., Segawa I., Tashiro A., Hiramori K. Tumor Necrosis Factor-α–Converting Enzyme and Tumor Necrosis Factor-α in Human Dilated Cardiomyopathy. Circulation. 1999;99:3260–3265. doi: 10.1161/01.CIR.99.25.3260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.99.25.3260</ArticleId><ArticleId IdType="pubmed">10385500</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure. N. Engl. J. Med. 1990;323:236–241. doi: 10.1056/NEJM199007263230405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199007263230405</ArticleId><ArticleId IdType="pubmed">2195340</ArticleId></ArticleIdList></Reference><Reference><Citation>Medeiros N.I., Gomes J.A.S., Fiuza J.A., Sousa G.R., Almeida E.F., Novaes R.O., Rocha V.L.S., Chaves A.T., Dutra W.O., Rocha M.O.C., et al. MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease. Sci. Rep. 2019;9:14170. doi: 10.1038/s41598-019-50791-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-50791-z</ArticleId><ArticleId IdType="pmc">PMC6775161</ArticleId><ArticleId IdType="pubmed">31578449</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermann D., Savvatis K., Schultheiss H.P., Tschöpe C. Immunomodulation and matrix metalloproteinases in viral myocarditis. J. Mol. Cell. Cardiol. 2010;48:468–473. doi: 10.1016/j.yjmcc.2009.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2009.08.019</ArticleId><ArticleId IdType="pubmed">19729021</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C., Marchant D., Walker E.K.-Y., Luo Z., Zhang J., Yanagawa B., Rahmani M., Cox J., Overall C., Senior R.M., et al. Ablation of Matrix Metalloproteinase-9 Increases Severity of Viral Myocarditis in Mice. Circulation. 2008;117:1574–1582. doi: 10.1161/CIRCULATIONAHA.107.733238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.733238</ArticleId><ArticleId IdType="pubmed">18332263</ArticleId></ArticleIdList></Reference><Reference><Citation>Diny N.L., Hou X., Barin J.G., Chen G., Talor M.V., Schaub J., Russell S.D., Klingel K., Rose N.R., Čiháková D. Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart. Eur. J. Immunol. 2016;46:2749–2760. doi: 10.1002/eji.201646557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201646557</ArticleId><ArticleId IdType="pmc">PMC5404278</ArticleId><ArticleId IdType="pubmed">27621211</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel R., He Z., Carmichael K.P., Halper J., Bateman A. Cellular Localization of Gene Expression for Progranulin. J. Histochem. Cytochem. 2000;48:999–1009. doi: 10.1177/002215540004800713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/002215540004800713</ArticleId><ArticleId IdType="pubmed">10858277</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Dienz O., Roberts B., Moussawi M., Rincon M., Huber S.A. IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis. Exp. Mol. Pathol. 2012;92:327–333. doi: 10.1016/j.yexmp.2012.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2012.03.009</ArticleId><ArticleId IdType="pmc">PMC3354021</ArticleId><ArticleId IdType="pubmed">22465422</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamo L., Rocha-Resende C., Lin C.-Y., Evans S., Williams J., Dun H., Li W., Mpoy C., Andhey P.S., Rogers B.E., et al. Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart. JCI Insight. 2020;5:e134700. doi: 10.1172/jci.insight.134700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.134700</ArticleId><ArticleId IdType="pmc">PMC7098796</ArticleId><ArticleId IdType="pubmed">31945014</ArticleId></ArticleIdList></Reference><Reference><Citation>Cen Z., Li Y., Wei B., Wu W., Huang Y., Lu J. The Role of B Cells in Regulation of Th Cell Differentiation in Coxsackievirus B3–Induced Acute Myocarditis. Inflammation. 2021;44:1949–1960. doi: 10.1007/s10753-021-01472-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-021-01472-5</ArticleId><ArticleId IdType="pubmed">33961174</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei B., Deng Y., Huang Y., Gao X., Wu W. IL-10-producing B cells attenuate cardiac inflammation by regulating Th1 and Th17 cells in acute viral myocarditis induced by coxsackie virus B3. Life Sci. 2019;235:116838. doi: 10.1016/j.lfs.2019.116838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.116838</ArticleId><ArticleId IdType="pubmed">31493482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M., Wen S., Wang M., Liang W., Li H.-H., Long Q., Guo H.P., Liao Y.-H., Yuan J. TNF-α-Secreting B Cells Contribute to Myocardial Fibrosis in Dilated Cardiomyopathy. J. Clin. Immunol. 2013;33:1002–1008. doi: 10.1007/s10875-013-9889-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-013-9889-y</ArticleId><ArticleId IdType="pubmed">23558825</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoian I., Oros A., Moldoveanu E. Apoptosis and Free Radicals. Biochem. Mol. Med. 1996;59:93–97. doi: 10.1006/bmme.1996.0072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bmme.1996.0072</ArticleId><ArticleId IdType="pubmed">8986629</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsutamoto T., Wada A., Matsumoto T., Maeda K., Mabuchi N., Hayashi M., Tsutsui T., Ohnishi M., Sawaki M., Fujii M., et al. Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. 2001;37:2086–2092. doi: 10.1016/S0735-1097(01)01299-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(01)01299-2</ArticleId><ArticleId IdType="pubmed">11419892</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y., Zhang H., Yu J., Wei L., Li M., Xu W. Stem cell factor/mast cell/CCL2/monocyte/macrophage axis promotes Coxsackievirus B3 myocarditis and cardiac fibrosis by increasing Ly6Chigh monocyte influx and fibrogenic mediators production. Immunology. 2022;167:590–605. doi: 10.1111/imm.13556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13556</ArticleId><ArticleId IdType="pubmed">36054617</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamdani N., Herwig M., Linke W.A. Tampering with springs: Phosphorylation of titin affecting the mechanical function of cardiomyocytes. Biophys. Rev. 2017;9:225–237. doi: 10.1007/s12551-017-0263-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12551-017-0263-9</ArticleId><ArticleId IdType="pmc">PMC5498327</ArticleId><ArticleId IdType="pubmed">28510118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kötter S., Kazmierowska M., Andresen C., Bottermann K., Grandoch M., Gorressen S., Heinen A., Moll J.M., Scheller J., Gödecke A., et al. Titin-Based Cardiac Myocyte Stiffening Contributes to Early Adaptive Ventricular Remodeling After Myocardial Infarction. Circ. Res. 2016;119:1017–1029. doi: 10.1161/CIRCRESAHA.116.309685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.309685</ArticleId><ArticleId IdType="pubmed">27650557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kötter S., Gout L., Von Frieling-Salewsky M., Müller A.E., Helling S., Marcus K., Dos Remedios C., Linke W.A., Krüger M. Differential changes in titin domain phosphorylation increase myofilament stiffness in failing human hearts. Cardiovasc. Res. 2013;99:648–656. doi: 10.1093/cvr/cvt144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvt144</ArticleId><ArticleId IdType="pubmed">23764881</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T., Narazaki M., Kishimoto T. Therapeutic Targeting of the Interleukin-6 Receptor. Annu. Rev. Pharmacol. Toxicol. 2012;52:199–219. doi: 10.1146/annurev-pharmtox-010611-134715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010611-134715</ArticleId><ArticleId IdType="pubmed">21910626</ArticleId></ArticleIdList></Reference><Reference><Citation>Sébert M., Sola-Tapias N., Mas E., Barreau F., Ferrand A. Protease-Activated Receptors in the Intestine: Focus on Inflammation and Cancer. Front. Endocrinol. 2019;10:717. doi: 10.3389/fendo.2019.00717.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2019.00717</ArticleId><ArticleId IdType="pmc">PMC6821688</ArticleId><ArticleId IdType="pubmed">31708870</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuberger D.M., Schuepbach R.A. Protease-activated receptors (PARs): Mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases. Thromb. J. 2019;17:4. doi: 10.1186/s12959-019-0194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-019-0194-8</ArticleId><ArticleId IdType="pmc">PMC6440139</ArticleId><ArticleId IdType="pubmed">30976204</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J., Liu Z., Lim T., Zhang H., He J., Walker E., Shier C., Wang Y., Su Y., Sall A., et al. CXCL10 Inhibits Viral Replication Through Recruitment of Natural Killer Cells in Coxsackievirus B3-Induced Myocarditis. Circ. Res. 2009;104:628–638. doi: 10.1161/CIRCRESAHA.108.192179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.108.192179</ArticleId><ArticleId IdType="pubmed">19168435</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode M.F., Schmedes C.M., Egnatz G.J., Bharathi V., Hisada Y.M., Martinez D., Kawano T., Weithauser A., Rosenfeldt L., Rauch U., et al. Cell type-specific roles of PAR1 in Coxsackievirus B3 infection. Sci. Rep. 2021;11:14264. doi: 10.1038/s41598-021-93759-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93759-8</ArticleId><ArticleId IdType="pmc">PMC8275627</ArticleId><ArticleId IdType="pubmed">34253819</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamud Y., Shi J., Qu J., Poon T., Xue Y.C., Deng H., Zhang J., Luo H. Enteroviral Infection Inhibits Autophagic Flux via Disruption of the SNARE Complex to Enhance Viral Replication. Cell Rep. 2018;22:3292–3303. doi: 10.1016/j.celrep.2018.02.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.02.090</ArticleId><ArticleId IdType="pubmed">29562184</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>